Key result
Dantrolene inhibits RyR2 domain unzipping and spontaneous Ca2+ leak with an IC50 of ~0.3 μmol/L.
Why the study?
Inter-domain interaction between the N-terminal and Central domains of the ryanodine receptor plays an important role in channel regulation, motivating investigation of the effect of dantrolene on Ca2+ release and cardiomyocyte function in failing hearts.
Does dantrolene stabilize inter-domain interactions within RyR2, inhibit spontaneous Ca2+ leak, and improve cardiomyocyte function in pacing-induced failing dog hearts?
Does dantrolene stabilize inter-domain interactions within RyR2, inhibit spontaneous Ca2+ leak, and improve cardiomyocyte function in pacing-induced failing dog hearts?
Dantrolene stabilizes defective inter-domain interactions within cardiac RyR2 to inhibit diastolic Ca2+ leak and delayed afterdepolarizations, suggesting a potential therapeutic strategy for heart failure and lethal arrhythmias.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for dantrolene in experimental HF; leaves open clinical translation of RyR2 stabilization.
Objectives To investigate the effect of dantrolene, a drug generally used to treat Malignant Hyperthermia (MH), on the Ca2+ release and cardiomyocyte function in failing hearts. Background The N-terminal (N: 1-600) and Central (C: 2000-2500) domains of the ryanodine receptor (RyR), harbor many mutations associated with MH in skeletal muscle RyR (RyR1) and polymorphic ventricular tachycardia in cardiac RyR (RyR2). There is strong evidence that inter-domain interaction between these regions plays an important role in the mechanism of channel regulation. Methods Sarcoplasmic reticulum (SR) vesicles and cardiomyocytes were isolated from dog LV muscles (normal or rapid ventricular pacing for 4 weeks), for Ca2+ leak, transient, and spark assays. To assess the zipped or unzipped state of the interacting domains, the RyR was fluorescently labeled with methylcoumarin acetate in a site-directed manner. We employed a quartz-crystal microbalance technique to identify the dantrolene binding site within the RyR2. Results Dantrolene specifically bound to domain 601-620 in RyR2. In the SR isolated from pacing-induced dog failing hearts, the defective inter-domain interaction_(domain unzipping) has already occurred, causing spontaneous Ca2+ leak. Dantrolene suppressed both domain unzipping and the Ca2+ leak, showing identical drug concentration-dependence (IC50=0.3 μmol/L). In failing cardiomyocytes, both diastolic Ca2+ sparks and delayed afterdepolarization were frequently observed, but 1 μmol/L dantrolene inhibited both events. Conclusions Dantrolene corrects defective inter-domain interactions within RyR2 in failing hearts, inhibits spontaneous Ca2+ leak, in turn improves cardiomyocyte function in failing hearts. Thus, dantrolene may have a potential to treat heart failure, specifically targeting the RyR2.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2009) studied Pacing-induced heart failure in dogs. Dantrolene vs. Untreated control or normal cardiomyocytes/sarcoplasmic reticulum vesicles was evaluated on Inhibition of RyR2 domain unzipping and spontaneous sarcoplasmic reticulum Ca2+ leak (IC50 0.3 μmol/L). Dantrolene suppressed both RyR2 domain unzipping and spontaneous Ca2+ leak in failing dog hearts with identical concentration-dependence and inhibited diastolic Ca2+ sparks at 1 μmol/L.
Synapse has enriched 10 related papers. Consider them for comparative context: